FOLD logo

Amicus Therapeutics (FOLD) Non Current Assets

Annual Non Current Assets

$294.82 M
-$5.53 M-1.84%

December 31, 2023

Summary

Performance

1-Year Change

-1.84%

3-Year Change

-3.98%

5-Year Change

+23.43%

15-Year Change

+25.42%

FOLD Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.21%
FOLD annual long term assets is higher than 80.21% of companies in Healthcare sector

High & Low

All-time High

$696.78 M
FOLD annual long term assets is currently -57.69% below its historical high of $696.78 million

3-Year Low

$294.82 M
FOLD annual long term assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FOLD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FOLD next annual earnings announcement is scheduled for Feb 28, 2025

OtherFOLDbalance sheetmetrics:

Annual Total Assets

$777.88 M
FOLD annual total assets is $777.88 million

Annual Current Assets

$483.06 M
FOLD annual total current assets is $483.06 million

Annual Total Liabilities

$617.71 M
FOLD annual total liabilities is $617.71 million

Annual Total Long Term Liabilities

$450.02 M
FOLD annual total long term liabilities is $450.02 million

Quarterly Non Current Assets

$288.08 M
+$300.00 K+0.10%

September 30, 2024

Summary

Performance

3-Month Change

+0.1%

1-Year Change

-4.24%

3-Year Change

-4.24%

5-Year Change

-4.24%

FOLD Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.5%
FOLD quarterly long term assets is higher than 79.5% of companies in Healthcare sector

High & Low

All-time High

$746.64 M
FOLD quarterly long term assets is currently -61.42% below its historical high of $746.64 million

3-Year Low

$287.78 M
FOLD quarterly long term assets is currently +0.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FOLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FOLD next earnings announcement is scheduled for Feb 28, 2025

OtherFOLDbalance sheetmetrics:

Quarterly Total Assets

$786.56 M
FOLD quarterly total assets is $786.56 million

Quarterly Current Assets

$498.47 M
FOLD quarterly total current assets is $498.47 million

Quarterly Total Liabilities

$607.73 M
FOLD quarterly total liabilities is $607.73 million

Quarterly Long Term Liabilities

$449.59 M
FOLD quarterly total long term liabilities is $449.59 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

FOLD Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.8%-4.2%
3 y3 years-4.0%-4.2%
5 y5 years+23.4%-4.2%

FOLD Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-4.4%at low-6.6%+0.1%
5 y5-year-10.7%at low-12.8%+0.1%
alltimeall time-57.7%>+9999.0%-61.4%>+9999.0%

Amicus Therapeutics Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$288.08 M(+0.1%)
Jun 2024
-
$287.78 M(-1.0%)
Mar 2024
-
$290.55 M(-1.4%)
Dec 2023
$483.06 M(+14.0%)
$294.82 M(-2.0%)
Sep 2023
-
$300.83 M(+1.2%)
Jun 2023
-
$297.27 M(-1.2%)
Mar 2023
-
$300.82 M(+0.2%)
Dec 2022
$423.82 M(-29.0%)
$300.35 M(-0.2%)
Sep 2022
-
$300.99 M(-0.6%)
Jun 2022
-
$302.95 M(-1.7%)
Mar 2022
-
$308.04 M(-0.1%)
Dec 2021
$596.83 M(+3.0%)
$308.31 M(+0.7%)
Sep 2021
-
$306.13 M(-0.1%)
Jun 2021
-
$306.39 M(-0.2%)
Mar 2021
-
$307.14 M(+0.0%)
Dec 2020
$579.47 M(+11.4%)
$307.05 M(-2.6%)
Sep 2020
-
$315.26 M(-0.7%)
Jun 2020
-
$317.57 M(-3.9%)
Mar 2020
-
$330.40 M(+0.1%)
Dec 2019
$520.07 M(-5.6%)
$330.13 M(+8.0%)
Sep 2019
-
$305.63 M(+7.9%)
Jun 2019
-
$283.16 M(+0.5%)
Mar 2019
-
$281.66 M(+17.9%)
Dec 2018
$551.10 M(+40.6%)
$238.85 M(+0.5%)
Sep 2018
-
$237.56 M(-4.8%)
Jun 2018
-
$249.66 M(-10.2%)
Mar 2018
-
$277.97 M(+18.3%)
Dec 2017
$391.96 M(+15.3%)
$235.06 M(-5.9%)
Sep 2017
-
$249.77 M(-64.2%)
Jun 2017
-
$697.98 M(+0.1%)
Mar 2017
-
$697.17 M(+0.1%)
Dec 2016
$340.06 M(+57.0%)
$696.78 M(+0.0%)
Sep 2016
-
$696.47 M(+0.0%)
Jun 2016
-
$696.33 M(+0.3%)
Mar 2016
-
$694.39 M(+0.4%)
Dec 2015
$216.60 M
$691.78 M(-7.3%)
DateAnnualQuarterly
Sep 2015
-
$746.64 M(+1818.6%)
Jun 2015
-
$38.92 M(-5.9%)
Mar 2015
-
$41.37 M(-25.3%)
Dec 2014
$154.58 M(+75.1%)
$55.39 M(+44.8%)
Sep 2014
-
$38.25 M(-0.8%)
Jun 2014
-
$38.57 M(-0.9%)
Mar 2014
-
$38.91 M(-1.0%)
Dec 2013
$88.28 M(-15.6%)
$39.28 M(+718.8%)
Sep 2013
-
$4.80 M(-7.0%)
Jun 2013
-
$5.16 M(-4.6%)
Mar 2013
-
$5.40 M(-1.2%)
Dec 2012
$104.62 M(+57.0%)
$5.47 M(-4.6%)
Sep 2012
-
$5.74 M(-3.3%)
Jun 2012
-
$5.93 M(+7.5%)
Mar 2012
-
$5.51 M(+75.2%)
Dec 2011
$66.65 M(-39.2%)
$3.15 M(+27.3%)
Sep 2011
-
$2.47 M(+13.0%)
Jun 2011
-
$2.19 M(-12.6%)
Mar 2011
-
$2.50 M(-12.8%)
Dec 2010
$109.68 M(+36.3%)
$2.87 M(-12.6%)
Sep 2010
-
$3.28 M(-12.2%)
Jun 2010
-
$3.74 M(-11.0%)
Mar 2010
-
$4.20 M(-14.0%)
Dec 2009
$80.49 M(-34.9%)
$4.88 M(-8.1%)
Sep 2009
-
$5.32 M(-5.0%)
Jun 2009
-
$5.59 M(+4.7%)
Mar 2009
-
$5.34 M(+3.0%)
Dec 2008
$123.59 M(-24.2%)
$5.19 M(+5.4%)
Sep 2008
-
$4.92 M(+10.3%)
Jun 2008
-
$4.46 M(+14.5%)
Mar 2008
-
$3.90 M(-3.9%)
Dec 2007
$163.04 M(+196.3%)
$4.06 M(-2.9%)
Sep 2007
-
$4.18 M(-5.6%)
Jun 2007
-
$4.43 M(-10.6%)
Mar 2007
-
$4.96 M(+7.1%)
Dec 2006
$55.02 M(+121.3%)
$4.63 M(+21.4%)
Dec 2005
$24.86 M
$3.81 M

FAQ

  • What is Amicus Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Amicus Therapeutics?
  • What is Amicus Therapeutics annual non current assets year-on-year change?
  • What is Amicus Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly non current assets year-on-year change?

What is Amicus Therapeutics annual long term assets?

The current annual non current assets of FOLD is $294.82 M

What is the all time high annual non current assets for Amicus Therapeutics?

Amicus Therapeutics all-time high annual long term assets is $696.78 M

What is Amicus Therapeutics annual non current assets year-on-year change?

Over the past year, FOLD annual long term assets has changed by -$5.53 M (-1.84%)

What is Amicus Therapeutics quarterly long term assets?

The current quarterly non current assets of FOLD is $288.08 M

What is the all time high quarterly non current assets for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly long term assets is $746.64 M

What is Amicus Therapeutics quarterly non current assets year-on-year change?

Over the past year, FOLD quarterly long term assets has changed by -$12.74 M (-4.24%)